about
Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniquesComplication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role?Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen.Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis.Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximated genetic subtypes.Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancerRadiation therapy in primary orbital lymphoma: a single institution retrospective analysis.Fractionated stereotactic radiation therapy for orbital optic nerve sheath meningioma - a single institution experience and a short review of the literature.Multivariate normal tissue complication probability modeling of heart valve dysfunction in Hodgkin lymphoma survivors.Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury.Automated delineation of brain structures in patients undergoing radiotherapy for primary brain tumors: from atlas to dose-volume histograms.Modeling the risk of radiation-induced lung fibrosis: Irradiated heart tissue is as important as irradiated lung.In Regard to Boomsma et alThyroid V30 Predicts Radiation-Induced Hypothyroidism in Patients Treated With Sequential Chemo-Radiotherapy for Hodgkin’s LymphomaDosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin’s lymphoma
P50
Q33894885-5719824B-E335-400F-83DA-C9EB4B482357Q34435278-FB85649C-08C2-4501-A8C6-BD49D61A0585Q35500065-42FC70F4-2948-430E-B9E6-2B11594720E5Q35743480-6CCD2414-A8FB-44C1-9BC0-1629DA026DBCQ36614170-451C3C15-B0BB-4E52-8B59-7E759305FD2EQ36661360-A9B0282E-D2F9-4D4C-B1F2-9EFF65CA2FBFQ37366354-AEDF0E3B-AE72-4622-8532-453178824A7BQ37479773-B8706D62-8781-4EE2-B08A-A5EDCC2C8B14Q37835609-41736BC6-7194-4820-81EF-A23E415877D4Q46044987-9A03D8E5-C48D-436B-89DC-603508874C92Q46662101-F5339292-EBD9-47E0-A216-394142B43A5AQ48665604-D39E9792-0457-4721-B09C-1CE3DD8A1B48Q53383461-6CE9EF4C-C626-4CFB-BC3F-974A441EB138Q60177854-D67C5D7C-D8A3-4B4A-A76F-C60C5D422C44Q60177869-3316431C-CB50-4590-88FD-7111A7D4F6EFQ60177871-DBD94CB1-ED49-47F1-8F63-3956A41093C2
P50
description
researcher ORCID ID = 0000-0002-0495-3656
@en
wetenschapper
@nl
name
Manuel Conson
@ast
Manuel Conson
@en
Manuel Conson
@es
Manuel Conson
@nl
type
label
Manuel Conson
@ast
Manuel Conson
@en
Manuel Conson
@es
Manuel Conson
@nl
prefLabel
Manuel Conson
@ast
Manuel Conson
@en
Manuel Conson
@es
Manuel Conson
@nl
P106
P1153
35261825700
P21
P31
P496
0000-0002-0495-3656